FDA clears Pluristem radiation treatment for emergency use
HAIFA, Israel (Reuters) - Pluristem Therapeutics Inc, a developer of placenta-based stem cell products, said the U.S. Food and Drug Administration has cleared the emergency use of its therapy to treat acute radiation exposure in a nuclear event.
from Reuters: Health News https://reut.rs/2JDoLND
http://bit.ly/2zwRqiM